Related Experiment Video
Updated: Dec 25, 2025

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
Published on: August 15, 2025
The Changing Spectrum of Sexually Transmitted Infections in Europe
1Outpatients Centre for the Diagnosis of Infectious Venerodermatological Diseases, Franz Jonasplatz 8-2-3, AT-1210 Vienna, Austria. angelika.stary@meduniwien.ac.at.
Sexually transmitted infections (STIs) are increasing globally, with rising syphilis rates and antibiotic resistance posing significant challenges. Prevention strategies, including vaccination and screening, are crucial for managing these infections and their long-term health consequences.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Historically, venereal diseases like syphilis and gonorrhea had high incidence and severe outcomes due to limited treatments.
- The advent of antibiotics post-WWII reduced infection rates, but a resurgence of STIs began in the 21st century.
- Current challenges include rising syphilis cases, particularly among men who have sex with men (MSM), and increasing antibiotic resistance in pathogens like Neisseria gonorrhoeae and Mycoplasma genitalium.
Purpose of the Study:
- To review the historical trends and current epidemiology of sexually transmitted infections (STIs).
- To highlight the growing challenges posed by antibiotic resistance and viral STIs.
- To emphasize the importance of current prevention and screening strategies for STIs and associated conditions like genital cancer.
Main Methods:
- Literature review of historical and contemporary data on STIs.
- Analysis of trends in infection rates, particularly syphilis in Europe.
- Examination of challenges related to antibiotic resistance and viral infections.
- Overview of established sexual health services and prevention programs.
Main Results:
- A steady increase in STIs has been observed worldwide since the early 21st century.
- Syphilis incidence is rising in Europe, notably among MSM.
- Antibiotic resistance in Neisseria gonorrhoeae and Mycoplasma genitalium presents significant therapeutic difficulties.
- Viral genital infections are increasingly recognized as a therapeutic and preventive challenge.
Conclusions:
- Effective management of STIs requires addressing rising infection rates, antibiotic resistance, and viral pathogens.
- Sexual health services, screening programs, and human papillomavirus (HPV) vaccination are vital for preventing STIs and related cancers.
- Continued vigilance and adaptation of public health strategies are necessary to combat the evolving landscape of STIs.
Related Concept Videos
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Retrovirus Life Cycles
Principles of Disease Surveillance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

